Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Response to Dr Moser's Commentary

Response to Dr Moser's Commentary Abstract I believe the pressure to treat hypertension needs to be lessened, and the arguments provided by Moser do not subvert those which I1 and others2,3 have advanced in favor of a less aggressive approach. His defense of the overall Multiple Risk Factor Intervention Trial (MRFIT) study data seems sound, since the failure to show a significant difference in mortality between the special intervention (SI) and usual care (UC) groups almost certainly reflects the high degree of care given the UC group. According to Moser, these data "clearly support the concept that risk factor reduction decreases the incidence of coronary heart disease." References 1. Kaplan NM: Whom to treat: The dilemma of mild hypertension. Am Heart J 1981;101:867-870.Crossref 2. Freis ED: Should mild hypertension be treated? N Engl J Med 1982;307:306-309.Crossref 3. Alderman MH, Madhavan S: Management of the hypertensive patient: A continuing dilemma. Hypertension 1981;3:192-197.Crossref 4. Ventricular extrasystoles during thiazide treatment: Substudy of Medical Research Council mild hypertension trial. Medical Research Council Working Party on Mild to Moderate Hypertension. Br Med J 1983;287:1249-1253.Crossref 5. Struthers AD, Whitesmith R, Reid JL: Prior thiazide diuretic treatment increases adrenaline-induced hypokalaemia. Lancet 1983;1:1358-1361.Crossref 6. Kaplan NM: New approaches to the therapy of mild hypertension. Am J Cardiol 1983;51:621-627.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Internal Medicine American Medical Association

Response to Dr Moser's Commentary

Archives of Internal Medicine , Volume 144 (4) – Apr 1, 1984

Loading next page...
 
/lp/american-medical-association/response-to-dr-moser-s-commentary-owz3fbZZvE
Publisher
American Medical Association
Copyright
Copyright © 1984 American Medical Association. All Rights Reserved.
ISSN
0003-9926
eISSN
1538-3679
DOI
10.1001/archinte.1984.00350160152024
Publisher site
See Article on Publisher Site

Abstract

Abstract I believe the pressure to treat hypertension needs to be lessened, and the arguments provided by Moser do not subvert those which I1 and others2,3 have advanced in favor of a less aggressive approach. His defense of the overall Multiple Risk Factor Intervention Trial (MRFIT) study data seems sound, since the failure to show a significant difference in mortality between the special intervention (SI) and usual care (UC) groups almost certainly reflects the high degree of care given the UC group. According to Moser, these data "clearly support the concept that risk factor reduction decreases the incidence of coronary heart disease." References 1. Kaplan NM: Whom to treat: The dilemma of mild hypertension. Am Heart J 1981;101:867-870.Crossref 2. Freis ED: Should mild hypertension be treated? N Engl J Med 1982;307:306-309.Crossref 3. Alderman MH, Madhavan S: Management of the hypertensive patient: A continuing dilemma. Hypertension 1981;3:192-197.Crossref 4. Ventricular extrasystoles during thiazide treatment: Substudy of Medical Research Council mild hypertension trial. Medical Research Council Working Party on Mild to Moderate Hypertension. Br Med J 1983;287:1249-1253.Crossref 5. Struthers AD, Whitesmith R, Reid JL: Prior thiazide diuretic treatment increases adrenaline-induced hypokalaemia. Lancet 1983;1:1358-1361.Crossref 6. Kaplan NM: New approaches to the therapy of mild hypertension. Am J Cardiol 1983;51:621-627.Crossref

Journal

Archives of Internal MedicineAmerican Medical Association

Published: Apr 1, 1984

References